Cowen Wins Top Honors at M&A Advisor Awards
announced that Cowen was recognized at the 15th Annual M&A
Advisor Awards for Corporate and Strategic Deal of the Year (Over $25MM
– $50MM). Cowen won this award for its role in the restructuring of
Therapeutics, Inc.
Advisory Group
included among the best in the M&A industry. This award speaks to
Cowen’s ability to navigate clients through a complex process and
deliver an exceptional outcome. This award also reflects the experience
and skill we bring to each engagement and the trust that clients place
in us. Our team worked closely with our partners in health care
investment banking to obtain an outcome that would maximize shareholder
value for the client. The Bind Therapeutics transaction began with a
comprehensive financial and strategic review process that ultimately
concluded in its Section 363 sale to Pfizer.”
The M&A Advisor Awards honors and awards companies and professionals
whose activities set the standard for M&A transactions. Winners were
chosen from over 320 nominees, representing over 615 companies.
About
with its consolidated subsidiaries, provides alternative asset
management, investment banking, research, sales and trading and prime
brokerage services through its two business segments: Ramius and its
affiliates make up the Company’s alternative investment segment, while
up the Company’s broker-dealer segment. Ramius provides alternative
asset management solutions to a global client base and manages a
significant portion of Cowen’s proprietary capital.
and its affiliates offer industry focused investment banking for
growth-oriented companies, domain knowledge-driven research, a sales and
trading platform for institutional investors and a comprehensive suite
of prime brokerage services. Founded in 1918, the firm is headquartered
in
View source version on businesswire.com: http://www.businesswire.com/news/home/20161117005292/en/
Source:
Gagnier Communications
Dan Gagnier, 646-342-8087